Myriad Genetics
MYGN
#6699
Rank
C$0.92 B
Marketcap
C$9.90
Share price
-3.27%
Change (1 day)
-56.85%
Change (1 year)

Myriad Genetics (MYGN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$0.49 Billion

According to Myriad Genetics's latest financial reports the company's total liabilities are C$0.49 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Myriad Genetics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$0.46 B-2.77%
2023-12-31C$0.48 B13.49%
2022-12-31C$0.42 B-5.59%
2021-12-31C$0.44 B
2020-06-30C$0.66 B6.45%
2019-06-30C$0.62 B125.46%
2018-06-30C$0.27 B-51.97%
2017-06-30C$0.57 B233.84%
2016-06-30C$0.17 B32.09%
2015-06-30C$0.12 B16.14%
2014-06-30C$0.11 B41.4%
2013-06-30C$79.08 M41.29%
2012-06-30C$55.97 M31.89%
2011-06-30C$42.44 M10.54%
2010-06-30C$38.39 M3.87%
2009-06-30C$36.96 M-50.76%
2008-06-30C$75.06 M101.3%
2007-06-30C$37.28 M25.21%
2006-06-30C$29.78 M3.03%
2005-06-30C$28.9 M43.95%
2004-06-30C$20.08 M-22.91%
2003-06-30C$26.04 M-39.75%
2002-06-30C$43.23 M-12.41%
2001-06-30C$49.36 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Bio-Rad Laboratories
BIO
C$4.13 B 732.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
C$4.74 B 856.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
C$30.45 M-93.86%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$2.17 B 338.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$45.95 B 9,164.57%๐Ÿ‡บ๐Ÿ‡ธ USA